Ardelyx 관리
관리 기준 확인 3/4
Ardelyx CEO는 Mike Raab, Mar2009 에 임명되었습니다 의 임기는 15.67 년입니다. 총 연간 보상은 $ 4.12M, 17% 로 구성됩니다. 17% 급여 및 83% 보너스(회사 주식 및 옵션 포함). 는 $ 6.31M 가치에 해당하는 회사 주식의 0.52% 직접 소유합니다. 6.31M. 경영진과 이사회의 평균 재임 기간은 각각 4.2 년과 9.1 년입니다.
주요 정보
Mike Raab
최고 경영자
US$4.1m
총 보상
| CEO 급여 비율 | 17.0% |
| CEO 임기 | 15.7yrs |
| CEO 소유권 | 0.5% |
| 경영진 평균 재임 기간 | 4.2yrs |
| 이사회 평균 재임 기간 | 9.1yrs |
최근 관리 업데이트
Recent updates
Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability
Nov 14Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03
Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business
Oct 24Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14What To Expect For Ardelyx In The Coming Month
Oct 18CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$73m |
| Jun 30 2024 | n/a | n/a | -US$65m |
| Mar 31 2024 | n/a | n/a | -US$66m |
| Dec 31 2023 | US$4m | US$700k | -US$66m |
| Sep 30 2023 | n/a | n/a | -US$27m |
| Jun 30 2023 | n/a | n/a | -US$56m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$2m | US$650k | -US$67m |
| Sep 30 2022 | n/a | n/a | -US$114m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$153m |
| Dec 31 2021 | US$4m | US$650k | -US$158m |
| Sep 30 2021 | n/a | n/a | -US$151m |
| Jun 30 2021 | n/a | n/a | -US$125m |
| Mar 31 2021 | n/a | n/a | -US$105m |
| Dec 31 2020 | US$4m | US$633k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$85m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$91m |
| Dec 31 2019 | US$2m | US$595k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$103m |
| Jun 30 2019 | n/a | n/a | -US$104m |
| Mar 31 2019 | n/a | n/a | -US$100m |
| Dec 31 2018 | US$4m | US$575k | -US$91m |
| Sep 30 2018 | n/a | n/a | -US$53m |
| Jun 30 2018 | n/a | n/a | -US$50m |
| Mar 31 2018 | n/a | n/a | -US$53m |
| Dec 31 2017 | US$5m | US$555k | -US$64m |
보상 대 시장: Mike 의 총 보상 ($USD 4.12M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 5.37M ).
보상과 수익: 회사가 수익성이 없는 동안 Mike 의 보상이 증가했습니다.
CEO
Mike Raab (59 yo)
15.7yrs
테뉴어
US$4,118,144
보상
Mr. Michael G. Raab, also known as Mike, has been the Chief Executive Officer and President of Ardelyx, Inc. since March 2009. He is a Director of Tempest Therapeutics Inc. since May 2019 and its Chairman...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 15.7yrs | US$4.12m | 0.52% $ 6.3m | |
| Chief Legal & Administrative Officer and Secretary | 10.5yrs | US$1.63m | 0.081% $ 985.0k | |
| Chief Medical Officer | 4yrs | US$1.63m | 0.13% $ 1.6m | |
| Chief Financial & Operations Officer | 4.4yrs | US$1.73m | 0.12% $ 1.5m | |
| Senior VP of Finance & Chief Accounting Officer | 2.7yrs | 데이터 없음 | 0.039% $ 468.8k | |
| Vice President of Corporate Communications & Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Corporate Development & Strategy | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Human Resources Officer | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Chief Development Officer | 9.8yrs | US$1.63m | 0.23% $ 2.7m | |
| Chief Regulatory Affairs & Quality Assurance Officer | no data | US$1.70m | 0.13% $ 1.6m | |
| Advisor | 4.5yrs | US$1.04m | 0.19% $ 2.3m | |
| Chief Commercial Officer | less than a year | 데이터 없음 | 데이터 없음 |
4.2yrs
평균 재임 기간
60yo
평균 연령
경험이 풍부한 관리: ARDX 의 관리팀은 경험 ( 4.2 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 15.7yrs | US$4.12m | 0.52% $ 6.3m | |
| Independent Chairman of the Board | 15.7yrs | US$249.90k | 0.60% $ 7.3m | |
| Independent Director | 9.1yrs | US$214.90k | 0.097% $ 1.2m | |
| Independent Director | 10.7yrs | US$222.40k | 0.11% $ 1.3m | |
| Independent Director | 8.4yrs | US$202.40k | 데이터 없음 | |
| Independent Director | 4.7yrs | US$199.90k | 0.047% $ 564.0k | |
| Independent Director | 3.7yrs | US$202.40k | 0.040% $ 490.5k |
9.1yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: ARDX 의 이사회는 경험(평균 재직 기간 9.1 년)으로 간주됩니다.